Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants
Systemic sclerosis (scleroderma: SSc) is a multisystem, connective tissue disease of unknown aetiology characterized by vascular dysfunction, autoimmunity, and enhanced fibroblast activity resulting in fibrosis of the skin, heart, and lungs, and ultimately internal organ failure, and death. One of t...
Saved in:
Main Authors: | Audrey Dooley, K. Richard Bruckdorfer, David J. Abraham |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/521958 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
by: Natalie K. Kozij, et al.
Published: (2017-01-01) -
A Potential Concept In The Management of Tumors With Modulation of Prostaglandin, Nitric Oxide and Antioxidants
by: Noori S. Al-Waili
Published: (2007-01-01) -
Modulation of nitric oxide synthase activity in macrophages
by: P. G. Jorens, et al.
Published: (1995-01-01) -
Antioxidant Functions of Nitric Oxide Synthase in a Methicillin Sensitive Staphylococcus aureus
by: Manisha Vaish, et al.
Published: (2013-01-01) -
Nitric oxide modulates interleukin-2-induced proliferation in CTLL-2 cells
by: J. Padrón, et al.
Published: (1996-01-01)